Takeda

Takeda Is Said to Weigh Sale of Shire Eye Drug to Cut Debt
Bloomberg
Thu, 09/13/18 - 12:08 pm
Takeda
Shire
M&A
Xiidra
Takeda shuttering Chicago complex with 1,000 staffers in lead-up to Shire merger
Endpoints
Tue, 09/11/18 - 11:33 pm
Takeda
Shire
M&A
layoffs
Traditionalists at Takeda spark a family feud with CEO Christophe Weber over his $62B Shire takeover deal
Endpoints
Mon, 09/10/18 - 11:38 am
Takeda
Pharma CEOs
Christophe Weber
Shire
M&A
Shire Secures FDA Approval for HAE Drug Lanadelumab
BioSpace
Fri, 08/24/18 - 11:23 am
Shire
Takeda
HAE
hereditary angiodema
Takhzyro
lanadelumab
FDA
Janssen, Lundbeck and Takeda Raise Issues With FDA Draft Guidance on MDD Drugs
RAPS.org
Mon, 08/20/18 - 11:07 pm
FDA
JNJ
Janssen
Lundbeck
Takeda
major depressive disorder
drug development
Shire dodges pricing questions as lanadelumab’s big day nears
EP Vantage
Fri, 08/10/18 - 09:30 am
Takeda
HAE
lanadelumab
FDA
Third Rock and Takeda Fund $140 Million Startup to Create Regenerative Therapies for Liver Diseases
CP Wire
Wed, 08/8/18 - 09:37 am
Ambys Medicines
Takeda
Third Rock
Takeda announces new series of non-core-asset sales
GoinPharma
Fri, 08/3/18 - 09:48 am
Takeda
Shire
M&A
Top 10: Takeda’s late-stage pipeline will rely heavily on Shire drugs — but is it worth $62B?
Endpoints
Tue, 07/31/18 - 10:55 pm
Takeda
Shire
M&A
pH-Dependent Drug-Drug Interactions: Novartis, Merck, Gilead and More Weigh in
RAPS.org
Thu, 07/26/18 - 07:28 pm
Novartis
Merck
GSK
Gilead Sciences
Bayer
AstraZeneca
AbbVie
Takeda
FDA
DDIs
drug-drug interactions
proton pump inhibitors
More Positive Results For Takeda's Alunbrig Acquisition
CP Wire
Wed, 07/25/18 - 09:34 am
Takeda
Alunbrig
ALK-positive non-small cell lung cancer
More Positive Results For Takeda's Alunbrig Acquisition
Wed, 07/25/18 - 08:49 am
Takeda
Alunbrig
ALK-positive non-small cell lung cancer
Takeda Drug Achieves Primary Endpoint of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
CP Wire
Thu, 07/19/18 - 11:20 am
Takeda
vedolizumab
ulcerative colitis
Entyvio
Takeda Drug Achieves Primary Endpoint of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
Thu, 07/19/18 - 10:07 am
Takeda
Entyvio
ulcerative colitis
Chron's Disease
Takeda and Ovid Therapeutics Expand Clinical Program for TAK-935/OV935 with New Studies in Rare Developmental and Epileptic Encephalopathies (DEE)
CP Wire
Wed, 07/18/18 - 10:00 am
Takeda
Ovid Therapeutics
TAK-935/OV935
Takeda and Ovid Therapeutics Expand Clinical Program for TAK-935/OV935 with New Studies in Rare Developmental and Epileptic Encephalopathies (DEE)
Wed, 07/18/18 - 09:43 am
Takeda
Ovid Therapeutics
developmental epileptic encephalopathies
Takeda, Celgene Invest $6 Million in Presage Biosciences Cancer Testing Technology
BioSpace
Tue, 07/17/18 - 11:23 pm
Presage Biosciences
Takeda
Celgene
cancer
diagnostics
Takeda's Ninlaro Met Primary Endpoint in Ph III Trial In Patients with Multiple Myeloma Post Stem Cell Transplant
CP Wire
Wed, 07/11/18 - 10:15 am
Takeda
Ninlaro
Multiple Myeloma
FTC Clears Takeda's Acquisition of Shire
CP Wire
Tue, 07/10/18 - 11:46 am
FTC
M&A
Takeda
Shire
More than $100 Billion Spent on M&A in the First 6 Months of 2018
BioSpace
Thu, 07/5/18 - 10:28 pm
M&A
biotech
Celgene
Sanofi
Impact Biomedicines
Bioverativ
GSK
Takeda
Shire
JNJ

Pages